Tianeptine, first developed as a therapeutic drug in the 1980s, has ignited considerable controversy internationally. Unlike common antidepressants which act by elevating serotonin levels, tianeptine appears to enhance mood reuptake and influences glutamate , causing atypical effects . Its accessibility through unregulated channels , often without